文献速递儿童青少年精神

氨基酸失调代谢型:自闭症谱系障碍亚型诊断与个体化治疗的潜在生物标志物

Amino Acid Dysregulation Metabotypes: Potential Biomarkers for Diagnosis and Individualized Treatment for Subtypes of Autism Spectrum Disorder.
PubMed 文献 · Biol Psychiatry · 2018-09-06

该研究基于儿童自闭症代谢组计划(CAMP),比较516例自闭症谱系障碍(ASD)患儿与164例年龄匹配的典型发育儿童的血浆代谢物,识别出三种与ASD相关的氨基酸失调代谢型。谷氨酰胺、甘氨酸和鸟氨酸代谢型组合在16.7%的ASD受试者中可检测到,特异性96.3%,阳性预测值93.5%。研究提示这些代谢型可作为ASD早期诊断和分层靶向治疗的可行代谢检测指标。

要点

  • ASD患儿血浆氨基酸代谢失调呈普遍现象,与支链氨基酸(BCAA)水平负相关。
  • 谷氨酰胺、甘氨酸和鸟氨酸代谢型组合在16.7%的ASD受试者中可检出。
  • 该组合检测特异性96.3%,在ASD队列中阳性预测值93.5%。

核心结论

  • ASD相关的氨基酸失调代谢型可支持早期诊断和分层靶向治疗。

研究设计与样本

  • 基于儿童自闭症代谢组计划(CAMP),比较516例ASD患儿与164例年龄匹配的典型发育儿童的血浆代谢物。

主要发现

  • 识别出与BCAA水平负相关的氨基酸组,并发现三种ASD相关的氨基酸失调代谢型。
  • 谷氨酰胺、甘氨酸和鸟氨酸代谢型组合在16.7%的CAMP ASD受试者中可检出。

关键数值与推荐

  • 该代谢型组合检测特异性为96.3%,在ASD受试者队列中阳性预测值为93.5%。

临床怎么用

  • 基于代谢型的代谢检测可能辅助ASD早期诊断和亚型分层,以指导靶向治疗干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Autism spectrum disorder (ASD) is behaviorally and biologically heterogeneous and likely represents a series of conditions arising from different underlying genetic, metabolic, and environmental factors. There are currently no reliable diagnostic biomarkers for ASD. Based on evidence that dysregulation of branched-chain amino acids (BCAAs) may contribute to the behavioral characteristics of ASD, we tested whether dysregulation of amino acids (AAs) was a pervasive phenomenon in individuals with ASD. This is the first article to report results from the Children's Autism Metabolome Project (CAMP), a large-scale effort to define autism biomarkers based on metabolomic analyses of blood samples from young children. METHODS: Dysregulation of AA metabolism was identified by comparing plasma metabolites from 516 children with ASD with those from 164 age-matched typically developing children recruited into the CAMP. ASD subjects were stratified into subpopulations based on shared metabolic phenotypes associated with BCAA dysregulation. RESULTS: We identified groups of AAs with positive correlations that were, as a group, negatively correlated with BCAA levels in ASD. Imbalances between these two groups of AAs identified three ASD-associated amino acid dysregulation metabotypes. The combination of glutamine, glycine, and ornithine amino acid dysregulation metabotypes identified a dysregulation in AA/BCAA metabolism that is present in 16.7% of the CAMP subjects with ASD and is detectable with a specificity of 96.3% and a positive predictive value of 93.5% within the ASD subject cohort. CONCLUSIONS: Identification and utilization of metabotypes of ASD can lead to actionable metabolic tests that support early diagnosis and stratification for targeted therapeutic interventions.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Smith AM, King JJ, West PR, et al. Amino Acid Dysregulation Metabotypes: Potential Biomarkers for Diagnosis and Individualized Treatment for Subtypes of Autism Spectrum Disorder. Biol Psychiatry. 2018. PMID: 30446206. doi:10.1016/j.biopsych.2018.08.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。